A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development-Reference-Cited by-同舟云学术

A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development

Published:2009-08 Issue:4 Volume:78 Page:315-325
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Zhao Lei,Jin Weijun,Rader Daniel,Packard Chris,Feuerstein Giora

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference75 articles.

1. Once-daily pravastatin in patients with primary hypercholesterolemia: a dose–response study;Jones;Clin Cardiol,1991

2. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor;Nawrocki;Arterioscler Thromb Vasc Biol,1995

3. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia;Gagne;Circulation,2002

4. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study;Gordon;Am J Med,1977

5. HDL as a target in the treatment of atherosclerotic cardiovascular disease;Linsel-Nitschke;Nat Rev Drug Discov,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers;Reference Module in Biomedical Sciences;2021

2. The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients;International Journal of Molecular Sciences;2020-12-14

3. Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation;Current Pharmaceutical Design;2019-01-02

4. Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers;Alzheimer's & Dementia;2017-02-24

5. Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs;JACC: Basic to Translational Science;2017-02